Eric E. Allen
Merck & Co., Inc., Rahway, NJ, USA (United States) · 10 works · 217 citations · h-index 7
Top works
- Bromine as an oxidant for direct conversion of aldehydes to esters
- A nonpeptidic agonist ligand of the human C5a receptor: Synthesis, binding affinity optimization and functional characterization
- Quinazolinones 1: design and synthesis of potent quinazolinone- containing AT1-selective angiotensin-II receptor antagonists
- Functionalization and Utility of Bridging Ethers in the Transformations of Bicyclo[5.4.0]undecanes
- Quinazolinones 2: QSAR and in vivo characterization of AT1 selective AII antagonists
- Intramolecular dipolar addition of carbonyl ylides. Studies of substituted bicycloundecanones.
- New potent angiotensin II receptor antagonists containing phenylthiophenes and phenylfurans in place of the biphenyl moiety.
- ChemInform Abstract: A Nonpeptidic Agonist Ligand of the Human C5a Receptor: Synthesis, Binding Affinity Optimization and Functional Characterization.
- ChemInform Abstract: Functionalization and Utility of Bridging Ethers in the Transformations of Bicyclo(5.4.0)undecanes.
- ChemInform Abstract: Bromine as an Oxidant for Direct Conversion of Aldehydes to Esters.